The ISPOR Asia Consortium Industry Committee will host a virtual meeting at 8:00AM-9:00AM, US Eastern time, 01 July 2024 (Time Conversion). This complementary meeting brings together stakeholders interested in health technology innovation and health policy in the Asia Pacific region, particularly industry colleagues to connect and learn about healthcare hot topics. It features two presentations followed by a Q and A session. Dr. Takashi Fukuda will present a status update on Japan’s CEA Scheme, evaluation results and their impacts. Dr. Li-Ying (Grace) Huang will discuss how advancements in technology can enhance HTA production and update on HTA progress in Taiwan.

Moderator:

• Larry Z. Liu, MD, PhD, Executive Director, Outcomes Research, Value & Implementation, Merck & Co. Inc., Rahway, NJ, USA

Speakers:

• Takashi Fukuda, PhD, Director of Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan
• Li-Ying (Grace) Huang, MSc, PhD, Director of Division of Health Technology Assessment Center for Drug Evaluation (CDE), Taipei, Taiwan

To Register for this event, please visit here.